Journal Of Clinical And Experimental Hematopathology impact factor, indexing, ranking (2024)

Aim and Scope

The Journal Of Clinical And Experimental Hematopathology is a research journal that publishes research in the field of lymphoma, leukemia, macrophage, dendritic cell, hematology, hematopathology. This journal is published by the The Japanese Society for Lymphoreticular Tissue Research. The ISSN of this journal is .

Also, please check the following important details about journal of clinical and experimental hematopathology: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

journal of clinical and experimental hematopathology Indexing

The journal of clinical and experimental hematopathology is indexed in:

• UGC CARE
• Web of Science (ESCI)
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.

Journal Of Clinical And Experimental Hematopathology Impact Factor 2024

The latest impact factor of journal of clinical and experimental hematopathology is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.

Publication fee

According to journal website, the publication fee of journal of clinical and experimental hematopathology is around 150 USD; 15000 JPY.

The journal of clinical and experimental hematopathology has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Journal Of Clinical And Experimental Hematopathology?

If your research is related to lymphoma, leukemia, macrophage, dendritic cell, hematology, hematopathology, then visit the official website of journal of clinical and experimental hematopathology and send your manuscript.

Tips for publishing in Journal Of Clinical And Experimental Hematopathology:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the journal of clinical and experimental hematopathology publishes research articles in 11 weeks on an average.

Final Summary